AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Finrab D 30mg/20mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biofin Lifesciences

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Finrab D 30mg/20mg Tablet SR

Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with Finrab D 30mg/20mg SR tablets, a dual-action formulation. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and discomfort by neutralizing stomach acid and facilitating gas expulsion. Finrab D should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration depends on individual response and should continue as directed; premature discontinuation may lead to symptom recurrence or condition exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, generally transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Due to potential drowsiness and dizziness, avoid driving or activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to increased sedative effects. Lifestyle adjustments, including consuming cool milk and avoiding caffeine, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding.

Primary Ingredients of Finrab D 30mg/20mg Tablet SR

No text provided to rephrase.

Uses of Finrab D 30mg/20mg Tablet SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Finrab D 30mg/20mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Finrab D 30mg/20mg Tablet SR on an empty stomach.

Common Side effects of Finrab D 30mg/20mg Tablet SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Finrab D 30mg/20mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet whole; do not chew, crush, or divide it. Administer Finrab D 30mg/20mg SR Tablet on an empty stomach.

How Finrab D 30mg/20mg Tablet SR works:

Finrab D 30mg/20mg sustained-release tablets contain Domperidone and Rabeprazole, two active pharmaceutical ingredients. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract function by promoting efficient stomach and intestinal transit. Rabeprazole, a proton pump inhibitor (PPI), diminishes gastric acid secretion, thus alleviating acid reflux symptoms such as indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Finrab D 30mg/20mg SR tablets with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Finrab D 30mg/20mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Finrab D 30mg/20mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Finrab D 30mg/20mg Extended-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when administering Finrab D 30mg/20mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Finrab D 30mg/20mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Finrab D 30mg/20mg SR tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Finrab D 30mg/20mg Tablet SR :

Should you forget a Finrab D 30mg/20mg SR Tablet dose, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual schedule. Never take a double dose.

Facts to Know About Finrab D 30mg/20mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Gastrointestinal tract

FAQs on Finrab D 30mg/20mg Tablet SR

Finrab D 30mg/20mg sustained-release tablets contain domperidone and rabeprazole. This formulation manages heartburn, acidity, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It also addresses gastric and duodenal ulcers. Domperidone's action on gut motility facilitates improved food passage through the stomach, thus mitigating vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components of Finrab D 30mg/20mg Tablet SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring while taking this medication.
Indeed, Finrab D 30mg/20mg SR tablets may induce xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase fluid consumption. Maintain a water source nearby overnight. Reduce alcohol consumption and abstain from smoking. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Finrab D 30mg/20mg SR tablets may induce diarrhea as a side effect. If diarrhea occurs, increased fluid intake is recommended. Dietary adjustments, such as avoiding greasy or deep-fried foods, are also advisable. Consult your physician if diarrhea is persistent or if you observe symptoms of dehydration, such as reduced urination and dark, concentrated urine.
Maintain this medication within its original, securely sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Finrab D 30mg/20mg SR tablets are generally well-tolerated. Nonetheless, some individuals may experience side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issue to your physician during treatment.
Optimal administration of Finrab D 30mg/20mg sustained-release tablets is before breakfast or on an empty stomach.
Indeed, taking Finrab D 30mg/20mg Extended-Release Tablets may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While a serious potential adverse effect, the probability of occurrence remains quite small. This risk might be marginally greater for individuals over sixty.
Finrab D 30mg/20mg sustained-release tablets contain domperidone and rabeprazole. This formulation addresses acidity, heartburn, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. The domperidone component aids in nausea control by promoting improved gut motility, facilitating efficient stomach emptying.
Finrab D 30mg/20mg Tablet SR should not be taken by individuals with documented allergies to rabeprazole, domperidone, or any auxiliary components of the medication. Patients with pre-existing liver or kidney conditions require careful monitoring while using this drug.
Indeed, taking Finrab D 30mg/20mg sustained-release tablets may lead to xerostomia (dry mouth), a side effect attributed to the domperidone component. To alleviate this, increased water consumption is recommended. Keeping water readily available overnight is advisable. Reducing alcohol intake and abstaining from smoking are also suggested. For dry mouth, consider using alcohol-free mouthwash to minimize the potential for dental caries.
Finrab D 30mg/20mg SR tablets may induce diarrhea. Should diarrhea occur, increased fluid intake is recommended. Fatty or greasy foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if symptoms of dehydration, such as reduced, dark, and strong-smelling urine, appear.
Finrab D 30mg/20mg SR tablets are generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as abdominal discomfort, diarrhea, flatulence, dry mouth, vertigo, and headache; less frequent or infrequent adverse reactions are also possible. Report any ongoing issue to your physician during treatment.
Optimal absorption of Finrab D 30mg/20mg sustained-release tablets is achieved by administering them before the initial meal or while fasting.
Taking Finrab D 30mg/20mg Tablet SR may raise the likelihood of experiencing an abnormal heart rhythm, a potentially severe adverse reaction. While this side effect is uncommon, it's a possibility. Individuals over 60 might face a marginally elevated risk.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure the medicine remains inaccessible to children, pets, and others.
Finrab D 30mg/20mg Tablet...
120
MRP 146
18% off